Patent · US Active

Anti-rabbit CD19 antibodies and methods of use

US12378315B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Alexander Haas · Munich, DE
Friederike Jung · Penzberg, DE
Stefan Klostermann · Schwanau, DE
Sonja Offner · Penzberg, DE

Key dates

Filing date	Jun 29, 2021
Grant date	Aug 5, 2025
Priority date	—
Expiry date	Feb 15, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2502/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Herein is reported an antibody binding to rabbit CD19 comprising (a) a HVR-H1 comprising the amino acid sequence of SEQ ID NO: 32 or 33 or 34, (b) a HVR-H2 comprising the amino acid sequence of SEQ ID NO: 35 or 36, (c) a HVR-H3 comprising the amino acid sequence of SEQ ID NO: 37, (d) a HVR-L1 comprising the amino acid sequence of SEQ ID NO: 38, (e) a HVR-L2 comprising the amino acid sequence of SEQ ID NO: 39, and (f) a HVR-L3 comprising the amino acid sequence of SEQ ID NO: 40, as well as methods of using the same, especially in the identification and selection of antibody producing rabbit B-cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.